<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Acute hemorrhagic erosive gastropathy and reactive gastropathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Acute hemorrhagic erosive gastropathy and reactive gastropathy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Acute hemorrhagic erosive gastropathy and reactive gastropathy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Pamela J Jensen, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark Feldman, MD, MACP, AGAF, FACG</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 30, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Injury to the gastric mucosa leads to epithelial cell damage and regeneration. Epithelial cell damage and reactive regeneration without associated inflammation is defined as "gastropathy" [<a href="#rid1">1,2</a>]. In contrast, the term gastritis is used to denote inflammation associated with gastric mucosal injury. A practical etiology-based framework for the classification of gastropathy and gastritis is presented [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/29.html" rel="external">"Gastritis: Etiology and diagnosis"</a>.)</p><p>This topic review will discuss acute hemorrhagic and erosive gastropathy and reactive gastropathy. The classification and diagnosis of gastritis, and the causes of acute and chronic gastritis are presented separately. (See  <a class="medical medical_review" href="/d/html/29.html" rel="external">"Gastritis: Etiology and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/31.html" rel="external">"Acute and chronic gastritis due to Helicobacter pylori"</a> and  <a class="medical medical_review" href="/d/html/30.html" rel="external">"Metaplastic (chronic) atrophic gastritis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ACUTE HEMORRHAGIC EROSIVE GASTROPATHY</span></p><p class="headingAnchor" id="H3643906053"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>Acute hemorrhagic erosive gastropathy is characterized by hemorrhagic and erosive lesions that develop shortly after exposure of the gastric mucosa to injurious substances or after a substantial reduction in mucosal blood flow (ischemic gastropathy). </p><p>Gastric and duodenal ulceroinflammatory lesions occurring during severe damage to the central nervous system (Cushing's ulcers) are often considered in this group, although some authorities consider them to be clinically and pathogenetically distinct [<a href="#rid3">3,4</a>]. (See  <a class="medical medical_review" href="/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"</a>.)</p><p class="headingAnchor" id="H3238420914"><span class="h3">Drugs/toxins</span><span class="headingEndMark"> — </span>The most frequent injurious agents include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alcohol</strong> – Alcohol exerts a direct toxic effect on gastric epithelium. In addition, it impairs gastric motility, leading to delayed gastric emptying and consequent prolonged mucosal contact time, further exacerbating the toxic injury [<a href="#rid5">5</a>]. Injury is dose-dependent and usually requires a gastric alcohol concentration of &gt;10 percent [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonsteroidal anti-inflammatory drugs (NSAIDs)</strong> – Damage can include acute hemorrhagic gastropathy, erosions, reactive gastropathy, ulcers, and perforation. Proton pump inhibitors (PPIs) have been used to mitigate gastrointestinal toxicity; however, there have been reports suggesting that PPIs can exacerbate NSAID-induced enteropathy, particularly within the small intestine [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/14.html" rel="external">"NSAIDs (including aspirin): Treatment and secondary prevention of gastroduodenal toxicity"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Iron pills</strong> – The consumption of large amounts of oral iron may lead to gastric mucosal necrosis, erosions, and ulcers. Brown pigment may be seen overlying the damaged epithelium [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Oral </strong><a class="drug drug_general" data-topicid="10269" href="/d/drug information/10269.html" rel="external">sodium phosphate</a><strong> preparations</strong> – Oral sodium phosphate preparations, used for colonoscopy bowel preparation, are associated with acute hemorrhagic gastropathy [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/2665.html" rel="external">"Bowel preparation before colonoscopy in adults", section on 'Sodium phosphate preparations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cancer chemotherapy</strong> – Damage to gastric mucosa in patients undergoing cancer chemotherapy is multifactorial and includes direct mucosal injury by the medication(s), vomiting-induced mucosal injury, and cancer-mediated or chemotherapy-induced immunosuppression (with opportunistic gastric infections). Hepatic arterial infusion of chemotherapy agents can produce alarming regenerative cellular atypia, easily confused with carcinoma [<a href="#rid10">10</a>].</p><p></p><p class="headingAnchor" id="H907811904"><span class="h3">Ischemia</span><span class="headingEndMark"> — </span>Cocaine can cause ischemic gastropathy by intense vasoconstriction with subsequent ischemia due to activation of alpha-adrenergic receptors in the mesentery [<a href="#rid11">11</a>]. Other causes of ischemic injury include hypovolemia, sepsis, trauma, and mucosal prolapse.</p><p class="headingAnchor" id="H2051344768"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>As a result of the acute mucosal injury, the normal protective barrier (which includes secreted mucins, bicarbonate, and the epithelium itself) is disrupted. This permits acid and other luminal substances (eg, pepsin and bile acids) to penetrate into the lamina propria, where they cause injury to the vasculature, stimulate nerves, and cause the release of histamine and other inflammatory mediators [<a href="#rid12">12,13</a>]. The mucosal injury increases significantly during the reperfusion that follows ischemia due to the production of toxic oxygen-free radicals by infiltrating neutrophils [<a href="#rid14">14</a>].</p><p>An additional pathogenetic factor in NSAID-induced acute hemorrhagic and erosive gastropathy is the inhibition of mucosal prostaglandin production. Prostaglandins protect against acute mucosal injury due to injurious substances by several mechanisms, including stimulation of mucus and bicarbonate secretion and increased vascular permeability, resulting in perivascular edema that dilutes and delays toxic agents reaching subepithelial capillaries [<a href="#rid15">15,16</a>]. (See  <a class="medical medical_review" href="/d/html/8.html" rel="external">"NSAIDs (including aspirin): Pathogenesis and risk factors for gastroduodenal toxicity"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Acute gastropathies often present with abdominal discomfort/pain, heartburn, nausea, vomiting, and hematemesis. Bleeding may be delayed until three to seven days following the stressful event and can range from occult blood to massive hemorrhage. Gastropathy (often referred to as gastritis) is commonly identified at the time of endoscopy, but such gastropathies rarely lead to significant upper gastrointestinal bleeding in the absence of other factors such as anticoagulation, coagulopathy or concurrent gastric/duodenal ulcers. (See  <a class="medical medical_review" href="/d/html/2644.html" rel="external">"Causes of upper gastrointestinal bleeding in adults", section on 'Gastritis/gastropathy and duodenitis/duodenopathy'</a> and  <a class="medical medical_review" href="/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Endoscopy and pathology</span></p><p class="headingAnchor" id="H4021107438"><span class="h3">Gastric erosions</span><span class="headingEndMark"> — </span>Acute hemorrhagic erosive gastropathy appears as multiple petechial hemorrhages and small red or black erosions on endoscopy [<a href="#rid17">17,18</a>]. Stress-related lesions (including Curling's ulcers) usually appear in the fundus near the gastroesophageal junction and spread distally, but remain confined to the fundus and body [<a href="#rid18">18</a>]. In contrast, gastropathy due to NSAIDs and alcohol ingestion involves the entire stomach from the start, although it may be most evident in the antrum [<a href="#rid18">18</a>]. The erosions in NSAID and alcohol-induced hemorrhagic gastropathy are usually smaller and more rapidly reversible than those seen in ischemic gastropathy [<a href="#rid18">18</a>].</p><p>Erosions may have only subtle histological features because mucosal restitution and repair are rapid. In many cases, an attenuated, regenerative-appearing epithelium provides the only evidence for their occurrence [<a href="#rid4">4</a>]. Inflammation is usually slight (consisting of no more than a few neutrophils) or absent. </p><p class="headingAnchor" id="H494533547"><span class="h3">Gastric/duodenal ulcers</span><span class="headingEndMark"> — </span>Acute hemorrhagic erosive gastropathy may be associated with the development of acute gastric and duodenal ulcers. Acute stress ulceration is most likely to occur in relation to shock-induced hemodynamic instability. Ulcers are usually multiple, shallow, 0.5 to 2.0 cm in diameter, and almost exclusively located in the corpus and fundus [<a href="#rid3">3,4,18,19</a>]. </p><p>The pathologic appearance of the ulcers depends upon their age. Ulcers initially appear necrotic, while older ulcers often demonstrate inflammation, granulation tissue, and epithelial cell regeneration. Ulcers of various ages can usually be found in the same patient [<a href="#rid19">19</a>].</p><p>Gastric (or duodenal) ulcers developing in the setting of acute hemorrhagic gastropathy may be associated with significant bleeding if they extend below the muscularis mucosae into deeper layers where large vessels are located [<a href="#rid3">3,4,19</a>]. Bleeding is more common from gastric than duodenal ulcers.</p><p class="headingAnchor" id="H7"><span class="h2">Management and prevention</span><span class="headingEndMark"> — </span>Management of acute hemorrhagic erosive gastropathy is based on the cause and the clinical presentation. Treatment includes removing the causative agent and employing a limited course of acid suppression with a PPI. Bleeding is typically self-limited. Additional measures that may be required include withholding anticoagulants when they may be contributing (if possible), and, if bleeding is severe, endoscopic therapy with modalities such as argon plasma coagulation. (See  <a class="medical medical_review" href="/d/html/2644.html" rel="external">"Causes of upper gastrointestinal bleeding in adults", section on 'Gastritis/gastropathy and duodenitis/duodenopathy'</a>.)</p><p>A variety of measures may also be effective for prevention of acute hemorrhagic gastropathy in high-risk patients. Examples include antisecretory agents (PPIs or H2 receptor antagonists) to prevent stress ulceration in the intensive care unit and for those undergoing cancer chemotherapy. (See  <a class="medical medical_review" href="/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">REACTIVE GASTROPATHY</span><span class="headingEndMark"> — </span>Reactive gastropathy is usually caused by long-term exposure of the gastric mucosa to substances capable of injuring the gastric mucosa (medications, ethanol, bile reflux), or by mucosal ischemia or vascular congestion. Reactive gastropathy is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, mucosal edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilation and congestion. </p><p class="headingAnchor" id="H3449181115"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>These changes were first recognized in severe bile reflux gastropathy [<a href="#rid20">20</a>], and have subsequently been observed in biopsy specimens from patients with chronic nonsteroidal anti-inflammatory drug (NSAID)-related mucosal injury [<a href="#rid21">21</a>]. <a class="drug drug_general" data-topicid="9427" href="/d/drug information/9427.html" rel="external">Alendronate</a>, which can cause acute gastropathy [<a href="#rid22">22</a>], can also cause reactive gastropathy.</p><p class="headingAnchor" id="H11"><span class="h3">Chronic NSAID use</span><span class="headingEndMark"> — </span>The pathogenetic connection between the acute hemorrhagic erosive gastropathy discussed above and the chronic reactive gastropathy associated with NSAIDs is not well understood. Continued, regular administration of NSAIDs in humans and experimental animals can lead to a reduction in visible hemorrhages and erosions as a result of mucosal adaptation [<a href="#rid23">23-27</a>]. However, many patients who take these drugs for prolonged periods continue to have ulceroinflammatory lesions with mucosal hemorrhages and erosions or, in approximately 15 percent of patients, gastric or duodenal ulceration [<a href="#rid28">28,29</a>]. This outcome has been referred to as "failed adaptation" [<a href="#rid30">30</a>]. <em>H. pylori</em> infection is known to exacerbate severe gastric mucosal injury in chronic NSAID users, possibly due to impairment of this adaptation process [<a href="#rid31">31</a>]. The chronic, poorly healing erosions and ulcers that often accompany NSAID-induced reactive gastropathy are usually associated with suppressed epithelial cell regeneration, which can be detected in biopsies obtained from the edge of ulcers [<a href="#rid32">32,33</a>]. The presence of scarring in the muscularis mucosae and submucosa in gastric resection specimens from NSAID users is also consistent with repeated episodes of erosion, ulceration, and repair. (See  <a class="medical medical_review" href="/d/html/8.html" rel="external">"NSAIDs (including aspirin): Pathogenesis and risk factors for gastroduodenal toxicity"</a>.)</p><p class="headingAnchor" id="H12"><span class="h3">Bile reflux gastropathy</span><span class="headingEndMark"> — </span>Bile reflux gastropathy typically results from the entry of bile into the stomach because of an operative stoma, an incompetent pyloric sphincter, or abnormal duodenal motility [<a href="#rid34">34</a>]. The degree of gastric injury reflects the amount of exposure to bile salts. Patients who have a gastroenterostomy, for example, demonstrate the greatest degree of foveolar hyperplasia near the stoma, with decreasing changes proximally [<a href="#rid20">20,35,36</a>]. Bile salt concentration in gastric juice correlates with the severity of foveolar hyperplasia in these patients.</p><p>The effect of bile salts on the gastric mucosa is comparable to that seen after chronic NSAID use [<a href="#rid34">34</a>]. Bile salts also appear to be a risk factor for the development of metaplastic (chronic) atrophic gastritis in the antrum [<a href="#rid37">37</a>]. Animal studies have demonstrated that bile salts and the phospholipid lysolecithin cause gastric mucosal injury [<a href="#rid38">38,39</a>]. Their degree of toxicity is influenced by a number of variables, including the type of bile salt, the presence or absence of deconjugation of bile salts by bacteria in the intestine or stomach, the gastric pH, and the presence of pancreatic enzymes. Pancreatic enzymes in particular enhance injury from bile salts, in part because they can catalyze formation of lysolecithin from lecithin. (See  <a class="medical medical_review" href="/d/html/30.html" rel="external">"Metaplastic (chronic) atrophic gastritis"</a>.)</p><p>Lysolecithin and bile salts break down the gastric mucosal barrier [<a href="#rid40">40</a>], leading to back-diffusion of hydrogen ions and mucosal injury [<a href="#rid38">38,39</a>]. Concomitant infection by <em>H. pylori</em> can increase inflammation [<a href="#rid41">41,42</a>]. Cytoprotection from bile-induced injury by prostaglandins has been demonstrated in animal studies [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H3824224183"><span class="h3">Other causes</span><span class="headingEndMark"> — </span>Other oral agents known to be injurious to gastric mucosa and likely causing reactive gastropathy with chronic use include potassium and iron supplements [<a href="#rid44">44-47</a>]. </p><p>Convincing evidence that smoking or alcohol causes reactive gastropathy are lacking [<a href="#rid5">5,21,23,48-50</a>]. Exposure of the gastric mucosa to alcohol is associated with acute hemorrhagic and erosive gastropathy (see <a class="local">'Drugs/toxins'</a> above) and chronic alcoholism correlates with presence of hemorrhagic and erosive lesions, [<a href="#rid51">51-53</a>]. Investigations directed at correlating alcohol consumption and chronic reactive gastropathy are difficult to conduct because of numerous confounding variables, including the presence of other potential causes of gastric injury such as NSAID use, <em>H. pylori</em> infection, and perhaps smoking. The types of alcoholic beverages consumed also may be important because of variations in alcohol concentration as well as important differences in content between distilled and fermented alcohols [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H1906189401"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Symptoms in patients with chronic bile acid reflux gastropathy and other forms of reactive gastropathy are variable, ranging from histologic changes only without symptoms to abdominal pain, bilious vomiting, and weight loss [<a href="#rid54">54</a>]. </p><p class="headingAnchor" id="H89290434"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of reactive gastropathy is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of upper abdominal symptoms. </p><p class="headingAnchor" id="H1968080701"><span class="h3">Endoscopy and histopathology</span><span class="headingEndMark"> — </span>Although there are no endoscopic findings that are diagnostic, mucosal changes are usually limited to hyperemia, and are confined to the antrum or gastroenterostomy sites. </p><p>Reactive gastropathy is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, mucosal edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilation and congestion [<a href="#rid20">20</a>]. Foveolar hyperplasia is characterized by lengthening of the foveolae, with individual cells having reduced height and depletion of intracellular mucin. The glands may take on a tortuous, corkscrew appearance in severe cases, as is commonly seen in biopsy specimens taken near gastroenterostomy stomas (in which gastropathy is usually due to bile reflux). Foveolar hyperplasia is part of a spectrum of hyperplastic changes that are found near gastroenterostomies; others include discrete polypoid lesions (ie, polypoid hypertrophic gastritis or gastritis cystica polyposa) [<a href="#rid35">35</a>]. Foveolar hyperplasia can regress after bile is diverted from the gastroenterostomies [<a href="#rid55">55</a>]. These changes were first recognized in severe bile reflux gastropathy [<a href="#rid20">20</a>], and have subsequently been observed in biopsy specimens from patients with chronic NSAID-related mucosal injury [<a href="#rid21">21</a>]. <a class="drug drug_general" data-topicid="9427" href="/d/drug information/9427.html" rel="external">Alendronate</a>, which can cause acute gastropathy [<a href="#rid22">22</a>], can also cause reactive gastropathy.</p><p class="headingAnchor" id="H3507309678"><span class="h2">Determining the etiology</span><span class="headingEndMark"> — </span>Whereas a potential cause of reactive gastropathy may be elicited based on initial history, it is often difficult to establish with certainty that a particular agent has caused gastropathy [<a href="#rid23">23,56,57</a>]. In patients with surgically altered anatomy, reactive gastropathy can be attributed to bile reflux gastropathy in the absence of other causes. In contrast, gastropathy in patients with non-operated stomachs should not be attributed to exposure to bile without evidence of duodenogastric reflux. Duodenogastric reflux can be demonstrated by visualization of bile in the stomach during endoscopy, bile salt analysis in gastric juice, or radionuclide scanning [<a href="#rid34">34,42,58,59</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Management</span><span class="headingEndMark"> — </span>Treatment includes removing the causative agent. In patients with symptomatic chronic bile acid reflux gastropathy, surgery to divert bile from refluxing into the stomach (usually a Roux-en-Y revision), has been associated with improvement in symptoms in 50 to 90 percent of patients in several case series [<a href="#rid54">54,60-62</a>]. Improvement is less likely in patients with delayed gastric emptying [<a href="#rid60">60</a>].</p><p>While a number of medical treatments have been evaluated, there are limited data to support their use:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10033" href="/d/drug information/10033.html" rel="external">Ursodeoxycholic acid</a><strong> (ursodiol)</strong> – In one small placebo-controlled crossover trial that included 12 patients with symptomatic bile reflux gastropathy, ursodeoxycholic acid for 1 month decreased pain and improved nausea and vomiting, but did not improve endoscopic appearance or histology [<a href="#rid63">63</a>]. A subsequent non-randomized trial suggested that ursodiol is superior to a proton pump inhibitor in these patients [<a href="#rid64">64</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9953" href="/d/drug information/9953.html" rel="external">Sucralfate</a> – Sucralfate improved histologic features but not symptoms in a randomized controlled trial that included 23 patients with symptoms of bile reflux gastropathy following Billroth I, Billroth II, or vagotomy and pyloroplasty [<a href="#rid65">65</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other</strong> – Prostaglandin E2 was ineffective in improving endoscopic features or symptoms in a double-blind crossover trial of bile reflux gastropathy [<a href="#rid66">66</a>]. <a class="drug drug_general" data-topicid="9258" href="/d/drug information/9258.html" rel="external">Cholestyramine</a> combined with alginates (to improve contact time in the gastric remnant) was also ineffective on symptoms or histology in a placebo-controlled trial that included 32 patients [<a href="#rid67">67</a>].</p><p></p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Injury to the gastric mucosa leads to epithelial cell damage and regeneration. Epithelial cell damage and regeneration without associated inflammation is defined as "gastropathy." (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute hemorrhagic erosive gastropathy is characterized by hemorrhagic and erosive lesions that develop shortly after exposure of the gastric mucosa to injurious substances or after a substantial reduction in mucosal blood flow. The most frequent injurious agents include drugs (eg, nonsteroidal anti-inflammatory drugs and alcohol), hypovolemia, and chronic congestion. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute hemorrhagic and erosive gastropathy appears as multiple petechial hemorrhages and small red or black erosions on endoscopy. Erosions may have only subtle histological features because mucosal restitution and repair are rapid. In many cases, an attenuated regenerative appearing epithelium provides the only evidence for their occurrence. Inflammation is usually minimal or absent. (See <a class="local">'Endoscopy and pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with acute hemorrhagic erosive gastropathy may present as abdominal discomfort, pain, heartburn, nausea, vomiting, and hematemesis. Bleeding may be seen three to seven days following the stressful event and can range from occult blood to massive hemorrhage. Gastropathy (often referred to as gastritis) is commonly identified at the time of endoscopy, but rarely lead to significant upper gastrointestinal bleeding in the absence of other factors such as anticoagulation or a coagulopathy or concurrent gastric/duodenal ulcers. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of acute hemorrhagic erosive gastropathy is based on the cause and the clinical presentation. Treatment includes removing the causative agent and a limited course of acid suppression with a proton pump inhibitor. Bleeding from gastropathy is typically self-limited. Additional measures that may be required include withholding anticoagulants when they may be contributing (if possible), and, if bleeding is severe, endoscopic therapy with modalities such as argon plasma coagulation. (See <a class="local">'Management and prevention'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reactive gastropathy is usually caused by long-term exposure to substances capable of injuring the gastric mucosa (medications, ethanol, bile), or by mucosal ischemia or vascular congestion. (See <a class="local">'Etiology'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms in patients with chronic bile reflux gastropathy and other forms of reactive gastropathy are variable. Patients may be asymptomatic or have symptoms of abdominal pain, bilious vomiting, and weight loss. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of reactive gastropathy is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of upper abdominal symptoms. Reactive gastropathy is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, mucosal edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilation and congestion. </p><p>(See <a class="local">'Endoscopy and histopathology'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>The presumed offending agent should be eliminated in patients with reactive gastropathy, if possible. In symptomatic patients with bile reflux gastropathy, surgery diverting bile from refluxing into the stomach is the definitive treatment. (See <a class="local">'Management'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161.</a></li><li><a class="nounderline abstract_t">Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995; 108:917.</a></li><li><a class="nounderline abstract_t">Marrone GC, Silen W. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions. Clin Gastroenterol 1984; 13:635.</a></li><li><a class="nounderline abstract_t">Silen W. The clinical problem of stress ulcers. Clin Invest Med 1987; 10:270.</a></li><li><a class="nounderline abstract_t">Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis 2005; 23:204.</a></li><li><a class="nounderline abstract_t">Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 1990; 98:909.</a></li><li><a class="nounderline abstract_t">Minalyan A, Gabrielyan L, Scott D, et al. The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Curr Gastroenterol Rep 2017; 19:42.</a></li><li><a class="nounderline abstract_t">Haig A, Driman DK. Iron-induced mucosal injury to the upper gastrointestinal tract. Histopathology 2006; 48:808.</a></li><li><a class="nounderline abstract_t">Nam SY, Choi IJ, Park KW, et al. Risk of hemorrhagic gastropathy associated with colonoscopy bowel preparation using oral sodium phosphate solution. Endoscopy 2010; 42:109.</a></li><li><a class="nounderline abstract_t">Petras RE, Hart WR, Bukowski RM. Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma. Cancer 1985; 56:745.</a></li><li><a class="nounderline abstract_t">Gourgoutis G, Das G. Gastrointestinal manifestations of cocaine addiction. Int J Clin Pharmacol Ther 1994; 32:136.</a></li><li><a class="nounderline abstract_t">Davenport HW. Salicylate damage to the gastric mucosal barrier. N Engl J Med 1967; 276:1307.</a></li><li><a class="nounderline abstract_t">Oates PJ, Hakkinen JP. Studies on the mechanism of ethanol-induced gastric damage in rats. Gastroenterology 1988; 94:10.</a></li><li><a class="nounderline abstract_t">Hernandez LA, Grisham MB, Twohig B, et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253:H699.</a></li><li><a class="nounderline abstract_t">Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77:433.</a></li><li><a class="nounderline abstract_t">Szabo S. "Gastric cytoprotection" is still relevant. J Gastroenterol Hepatol 2014; 29 Suppl 4:124.</a></li><li class="breakAll">Sloan JM. Acute haemorrhage gastritis and acute infective gastritis, gastritis caused by physical agents and corrosives, uraemic gastritis. In: Gastrointestinal and Oesophageal Pathology, Whitehead R (Ed), Churchill Livingstone, Edinburgh 1989. p.385.</li><li><a class="nounderline abstract_t">Sugawa C, Lucas CE, Rosenberg BF, et al. Differential topography of acute erosive gastritis due to trauma or sepsis, ethanol and aspirin. Gastrointest Endosc 1973; 19:127.</a></li><li><a class="nounderline abstract_t">Lev R, Molot MD, McNamara J, Stremple JF. "Stress" ulcers following war wounds in Vietnam. A morphologic and histochemical study. Lab Invest 1971; 25:491.</a></li><li><a class="nounderline abstract_t">Dixon MF, O'Connor HJ, Axon AT, et al. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986; 39:524.</a></li><li><a class="nounderline abstract_t">Sobala GM, King RF, Axon AT, Dixon MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43:303.</a></li><li><a class="nounderline abstract_t">Graham DY, Malaty HM, Goodgame R. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Am J Gastroenterol 1997; 92:1322.</a></li><li><a class="nounderline abstract_t">Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984; 13:405.</a></li><li><a class="nounderline abstract_t">Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104:390.</a></li><li><a class="nounderline abstract_t">Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. Arch Intern Med 1987; 147:2093.</a></li><li><a class="nounderline abstract_t">Shorrock CJ, Rees WD. Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism. Gut 1992; 33:164.</a></li><li><a class="nounderline abstract_t">Konturek SJ, Brzozowski T, Majka J, et al. Adaptation of the gastric mucosa to stress. Role of prostaglandin and epidermal growth factor. Scand J Gastroenterol Suppl 1992; 193:39.</a></li><li><a class="nounderline abstract_t">Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91:517.</a></li><li><a class="nounderline abstract_t">Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82:1153.</a></li><li><a class="nounderline abstract_t">Olivero JJ, Graham DY. Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol Suppl 1992; 193:53.</a></li><li><a class="nounderline abstract_t">Kono Y, Okada H, Takenaka R, et al. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study. Gut Liver 2016; 10:69.</a></li><li><a class="nounderline abstract_t">Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336:840.</a></li><li><a class="nounderline abstract_t">Myszor M, Hodgson HJ. Non-steroidal anti-inflammatory drugs and gastric DNA synthesis. Scand J Gastroenterol 1990; 25:197.</a></li><li><a class="nounderline abstract_t">Niemelä S. Duodenogastric reflux in patients with upper abdominal complaints or gastric ulcer with particular reference to reflux-associated gastritis. Scand J Gastroenterol Suppl 1985; 115:1.</a></li><li><a class="nounderline abstract_t">Koga S, Watanabe H, Enjoji M. Stomal polypoid hypertrophic gastritis: a polypoid gastric lesion at gastroenterostomy site. Cancer 1979; 43:647.</a></li><li><a class="nounderline abstract_t">Weinstein WM, Buch KL, Elashoff J, et al. The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol Suppl 1985; 109:77.</a></li><li><a class="nounderline abstract_t">Nakamura M, Haruma K, Kamada T, et al. Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 2001; 53:53.</a></li><li><a class="nounderline abstract_t">Orchard R, Reynolds K, Fox B, et al. Effect of lysolecithin on gastric mucosal structure and potential difference. Gut 1977; 18:457.</a></li><li><a class="nounderline abstract_t">Eastwood GL. Effect of pH on bile salt injury to mouse gastric mucosa. A light- and electron-microscopic study. Gastroenterology 1975; 68:1456.</a></li><li><a class="nounderline abstract_t">Davenport HW. Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 1968; 54:175.</a></li><li><a class="nounderline abstract_t">Loffeld RJ, Loffeld BC, Arends JW, et al. Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy. J Clin Pathol 1988; 41:1313.</a></li><li><a class="nounderline abstract_t">Karttunen T, Niemelä S. Campylobacter pylori and duodenogastric reflux in peptic ulcer disease and gastritis. Lancet 1988; 1:118.</a></li><li><a class="nounderline abstract_t">Dempsey DT, Mercer DW, Deb B, et al. Adaptive cytoprotection of gastric surface epithelial cells against injury by physiologic concentrations of bile acid. Surgery 1990; 108:348.</a></li><li><a class="nounderline abstract_t">McMahon FG, Ryan JR, Akdamar K, Ertan A. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial. Lancet 1982; 2:1059.</a></li><li><a class="nounderline abstract_t">Shafique K, Araujo JL, Veluvolu R, et al. Mitochondrial Iron Accumulation in Parietal and Chief Cells in Iron Pill Gastritis Following Billroth II Gastrectomy: Case Report Including Electron Microscopic Examination. Ann Clin Lab Sci 2017; 47:354.</a></li><li><a class="nounderline abstract_t">Meliţ LE, Mărginean CO, Mocanu S, Mărginean MO. A rare case of iron-pill induced gastritis in a female teenager: A case report and a review of the literature. Medicine (Baltimore) 2017; 96:e7550.</a></li><li><a class="nounderline abstract_t">Sunkara T, Caughey ME, Nigar S, et al. Iron Pill Gastritis: An Under Diagnosed Condition With Potentially Serious Outcomes. Gastroenterology Res 2017; 10:138.</a></li><li><a class="nounderline abstract_t">Cheli R, Giacosa A, Marenco G, et al. Chronic gastritis and alcohol. Z Gastroenterol 1981; 19:459.</a></li><li><a class="nounderline abstract_t">Oddsson E, Binder V, Thorgeirsson T, et al. A prospective comparative study of clinical and pathological characteristics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer, and X-ray negative dyspepsia. II. Histological results. Scand J Gastroenterol 1978; 13:489.</a></li><li><a class="nounderline abstract_t">Uppal R, Lateef SK, Korsten MA, et al. Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori. Arch Intern Med 1991; 151:760.</a></li><li><a class="nounderline abstract_t">Laine L, Weinstein WM. Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation. Gastroenterology 1988; 94:1254.</a></li><li><a class="nounderline abstract_t">Segawa K, Nakazawa S, Tsukamoto Y, et al. Endoscopic study of upper gastrointestinal tract in patients with alcohol dependence. Jpn J Med 1987; 26:21.</a></li><li><a class="nounderline abstract_t">Bernersen B, Johnsen R, Straume B, Burhol PG. Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The Sørreisa Gastrointestinal Disorder Study. Scand J Gastroenterol 1992; 27:233.</a></li><li><a class="nounderline abstract_t">Bondurant FJ, Maull KI, Nelson HS Jr, Silver SH. Bile reflux gastritis. South Med J 1987; 80:161.</a></li><li><a class="nounderline abstract_t">Bechi P, Amorosi A, Mazzanti R, et al. Short-term effects of bile diversion on postgastrectomy gastric histology. Dig Dis Sci 1988; 33:1288.</a></li><li><a class="nounderline abstract_t">Kurata JH, Elashoff JD, Grossman MI. Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding. Gastroenterology 1982; 82:373.</a></li><li><a class="nounderline abstract_t">Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology 2021; 161:1325.</a></li><li><a class="nounderline abstract_t">Stein HJ, Smyrk TC, DeMeester TR, et al. Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease. Surgery 1992; 112:796.</a></li><li><a class="nounderline abstract_t">Niemelä S, Karttunen T, Heikkilä J, Lehtola J. Characteristics of reflux gastritis. Scand J Gastroenterol 1987; 22:349.</a></li><li><a class="nounderline abstract_t">Davidson ED, Hersh T. The surgical treatment of bile reflux gastritis: a study of 59 patients. Ann Surg 1980; 192:175.</a></li><li><a class="nounderline abstract_t">Capussotti L, Marucci MM, Arico S, et al. Long-term results of surgical treatment for alkaline reflux gastritis in gastrectomized patients. Am J Gastroenterol 1984; 79:924.</a></li><li><a class="nounderline abstract_t">Tassé D, Ghosn PO, Gagnon M, et al. Alkaline reflux gastritis: Roux-en-Y diversion is effective. Can J Surg 1982; 25:337.</a></li><li><a class="nounderline abstract_t">Stefaniwsky AB, Tint GS, Speck J, et al. Ursodeoxycholic acid treatment of bile reflux gastritis. Gastroenterology 1985; 89:1000.</a></li><li><a class="nounderline abstract_t">Kumar N, Thompson CC. Remnant gastropathy due to bile reflux after Roux-en-Y gastric bypass: a unique cause of abdominal pain and successful treatment with ursodiol. Surg Endosc 2017; 31:5399.</a></li><li><a class="nounderline abstract_t">Buch KL, Weinstein WM, Hill TA, et al. Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study. Am J Med 1985; 79:49.</a></li><li><a class="nounderline abstract_t">Nicolai JJ, van de Stadt J, Tytgat GN. Double-blind crossover trial of prostaglandin E2 in postgastrectomy reflux gastritis. Dig Dis Sci 1986; 31:1281.</a></li><li><a class="nounderline abstract_t">Nicolai JJ, Speelman P, Tytgat GN, van der Stadt J. Comparison of the combination of cholestyramine/alginates with placebo in the treatment of postgastrectomy biliary reflux gastritis. Eur J Clin Pharmacol 1981; 21:189.</a></li></ol></div><div id="topicVersionRevision">Topic 36 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8827022" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7875496" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6430609" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2887324" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The clinical problem of stress ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16508284" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Alcohol-related diseases of the esophagus and stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2311875" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28733944" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16722929" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Iron-induced mucosal injury to the upper gastrointestinal tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20140827" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Risk of hemorrhagic gastropathy associated with colonoscopy bowel preparation using oral sodium phosphate solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3926293" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8205375" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Gastrointestinal manifestations of cocaine addiction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6024894" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Salicylate damage to the gastric mucosal barrier.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3335281" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Studies on the mechanism of ethanol-induced gastric damage in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3631303" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Role of neutrophils in ischemia-reperfusion-induced microvascular injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/456839" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25521744" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : "Gastric cytoprotection" is still relevant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25521744" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : "Gastric cytoprotection" is still relevant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4540828" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Differential topography of acute erosive gastritis due to trauma or sepsis, ethanol and aspirin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5129758" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : "Stress" ulcers following war wounds in Vietnam. A morphologic and histochemical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3722405" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Reflux gastritis: distinct histopathological entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2341566" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Reflux gastritis in the intact stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9260798" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6378444" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Gastroduodenal damage due to drugs, alcohol and smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3511824" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Aspirin and the stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3318750" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1541410" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1290057" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Adaptation of the gastric mucosa to stress. Role of prostaglandin and epidermal growth factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/314764" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3499815" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1290058" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Gastric adaptation to nonsteroidal anti-inflammatory drugs in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26087789" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1699093" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2320939" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Non-steroidal anti-inflammatory drugs and gastric DNA synthesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3863229" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Duodenogastric reflux in patients with upper abdominal complaints or gastric ulcer with particular reference to reflux-associated gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/421186" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Stomal polypoid hypertrophic gastritis: a polypoid gastric lesion at gastroenterostomy site.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3860923" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11154489" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Duodenogastric reflux is associated with antral metaplastic gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/873327" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Effect of lysolecithin on gastric mucosal structure and potential difference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/236971" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effect of pH on bile salt injury to mouse gastric mucosa. A light- and electron-microscopic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5711899" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Destruction of the gastric mucosal barrier by detergents and urea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3225333" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2891956" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Campylobacter pylori and duodenogastric reflux in peptic ulcer disease and gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2382230" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Adaptive cytoprotection of gastric surface epithelial cells against injury by physiologic concentrations of bile acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6127542" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28667040" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Mitochondrial Iron Accumulation in Parietal and Chief Cells in Iron Pill Gastritis Following Billroth II Gastrectomy: Case Report Including Electron Microscopic Examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28746201" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A rare case of iron-pill induced gastritis in a female teenager: A case report and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28496538" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Iron Pill Gastritis: An Under Diagnosed Condition With Potentially Serious Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7293294" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Chronic gastritis and alcohol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/675162" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A prospective comparative study of clinical and pathological characteristics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer, and X-ray negative dyspepsia. II. Histological results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2012461" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3258836" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3573406" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Endoscopic study of upper gastrointestinal tract in patients with alcohol dependence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1502487" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The Sørreisa Gastrointestinal Disorder Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3810208" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Bile reflux gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3168700" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Short-term effects of bile diversion on postgastrectomy gastric histology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6976283" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34454714" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1411953" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3589504" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Characteristics of reflux gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7406572" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The surgical treatment of bile reflux gastritis: a study of 59 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6507418" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Long-term results of surgical treatment for alkaline reflux gastritis in gastrectomized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7083083" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Alkaline reflux gastritis: Roux-en-Y diversion is effective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4043659" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Ursodeoxycholic acid treatment of bile reflux gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28799115" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Remnant gastropathy due to bile reflux after Roux-en-Y gastric bypass: a unique cause of abdominal pain and successful treatment with ursodiol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3839973" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3542441" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Double-blind crossover trial of prostaglandin E2 in postgastrectomy reflux gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7032948" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Comparison of the combination of cholestyramine/alginates with placebo in the treatment of postgastrectomy biliary reflux gastritis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
